Ranking & Metrics Conference Call for Papers Other Conferences in United States
AACR-NCI-EORTC VIRTUAL INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER THERAPEUTICS

AACR-NCI-EORTC VIRTUAL INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER THERAPEUTICS

Online

Submission Deadline: Wednesday 25 Aug 2021

Conference Dates: Oct 07, 2021 - Oct 10, 2021

Research
Impact Score 0.30

OFFICIAL WEBSITE

Conference Organizers: Deadline extended?
Click here to edit

Ranking & Metrics Impact Score is a novel metric devised to rank conferences based on the number of contributing the best scientists in addition to the h-index estimated from the scientific papers published by the best scientists. See more details on our methodology page.

Research Impact Score: 0.30
Contributing Best Scientists: 33
H5-index:
Papers published by Best Scientists 27
Research Ranking (Genetics and Molecular Biology) 6
Research Ranking (Immunology) 15
Research Ranking (Biology and Biochemistry) 8
Research Ranking (Medicine) 8

Conference Call for Papers

ABSTRACT CATEGORIES
Angiogenesis and antiangiogenesis agents
Animal models
Apoptosis, necrosis, and autophagy
Bioinformatics
Biomarkers Cancer stem cells
Cell cycle regulators
Cellular responses to therapy
Chemistry
Chemoprevention
Clinical trials
DNA repair and modulation
Drug delivery
Drug design
Drug metabolism, transport, and biodistribution
Drug resistance and modifiers
Drug screening
EGFR/Her2
Epigenetic regulation of tumor immunity
Epigenetic targets
Gene therapies
Genomics, proteomics, and target discovery
Heat shock proteins
Hormonal agents and therapy
Imaging
Immune checkpoints
Immune mechanisms invoked by radiation therapy
Immune modulators
Immune monitoring/clinical correlates
Immune response to therapies
In vitro and in vivo models for targets
MAPK pathways
Metabolism
Metastasis and invasion
Molecular classification of tumors
Monoclonal antibodies
mTOR/PI3-kinase
Natural products
New molecular targets
Novel assay technology
Pediatric-early drug development
Pharmacogenetics, pharmacogenomics, and therapeutic response
Pharmacokinetics and pharmacodynamics
Protein-protein interaction
Radiotherapeutics
RNA and RNA-based technologies and therapies
Signal transduction modulators
Target identification and validation
Therapeutic agents: biological
Therapeutic agents: other
Therapeutic agents: small-molecule kinase inhibitors
Topoisomerase inhibitors
Toxicology
Tubulin-interacting agents
Tumor immunology targets
Tumor microenvironment
Tumor suppressors
Other

Previous Editions

Something went wrong. Please try again later.